Scientists find promising new drug against rare, life-threatening kidney disease

A groundbreaking oral drug, N-propargylglycine (N-PPG), has shown remarkable success in preventing fatal kidney damage in mice with Primary Hyperoxaluria Type 2 (PH2). This rare genetic disorder causes excessive oxalate buildup, leading to kidney failure. The drug effectively halts stone formation and protects kidneys, offering significant hope for a new treatment and potentially reducing the need for transplants.